Carriers with germline alterations in BRCA1/2, BLM, CHEK2, and NTHL1 have all been reported to be at an elevated risk for developing early-onset CRC with unique histological characteristics [27,28,29,30]. Here, CHEK2 is linked to colorectal carcinoma.